Drug Profile
DTaP-hepatitis B-poliovirus vaccine - GSK
Alternative Names: Infanrix PeNta; Infanrix-HepB-IPV; InfanrixDTPa®-HepB-IPV; PediarixLatest Information Update: 02 Jul 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GSK; Nonindustrial source
- Class Bacterial vaccines; Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diphtheria; Hepatitis B; Pertussis; Poliomyelitis; Tetanus
Most Recent Events
- 09 Jan 2003 First global launch of PediarixTM in the US
- 09 Jan 2003 Launched for Diphtheria in USA (IM)
- 09 Jan 2003 Launched for Hepatitis B in USA (IM)